tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Elemer Piros, 148 are a BUY (84.09%), 15 are a HOLD (8.52%), 13 are a SELL (7.39%).
Analyst Elemer Piros, currently employed at BENCHMARK, carries an average stock price target met ratio of 45.53% that have a potential upside of 40.78% achieved within 228 days. Previously, Elemer Piros worked at ROTH.
Elemer Piros’s has documented 335 price targets and ratings displayed on 37 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ARWR, Arrowhead Pharmaceuticals at 08-Aug-2023.
Analyst best performing recommendations are on ARCT (ARCTURUS THERAPEUTICS HOLDINGS).
The best stock recommendation documented was for ARCT (ARCTURUS THERAPEUTICS HOLDINGS) at 3/2/2021. The price target of $45 was fulfilled within 3 days with a profit of $8.96 (16.6%) receiving and performance score of 55.35.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$15
$9.11 (154.67%)
$15
25 days ago
(25-Nov-2024)
0/6 (0%)
$8.95 (147.93%)
Buy
$18
$12.11 (205.60%)
$18
1 months 21 days ago
(29-Oct-2024)
1/6 (16.67%)
$11.43 (173.97%)
61
Hold
$6
$0.11 (1.87%)
$5
2 years 1 months 6 days ago
(14-Nov-2022)
2/3 (66.67%)
$1.85 (44.58%)
257
Buy
$75
$70.79 (1681.47%)
$50
4 years 1 months 10 days ago
(11-Nov-2020)
2/3 (66.67%)
$45.92 (117.11%)
101
Buy
$22
4 years 7 months 12 days ago
(08-May-2020)
1/3 (33.33%)
$-59.25 (-72.92%)
820
What Year was the first public recommendation made by Elemer Piros?
